6/17/2025 - 12:03 PM EST - Knight Therapeutics Inc. : Has entered into a revolving credit facility, with National Bank of Canada. Knight has withdrawn C$60 million from the Credit Facility to fund a portion of the Paladin acquisition. The Credit Facility provides Knight with an initial borrowing limit of up to US$50 million, which is mainly intended to support the Company's growth strategy and may also be used for working capital and other corporate purposes. Knight Therapeutics Inc.
shares T.GUD are trading up $0.10 at $6.12.
